In a patient with mild facial redness limited to the T‑zone and acne, and markedly erythematous arms with keratosis pilaris, what is the appropriate endocrine work‑up—should Cushing’s syndrome testing be performed or should the focus be on evaluating for polycystic ovary syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Focus on PCOS Evaluation, Not Cushing's Syndrome Testing

In a patient with mild facial redness limited to acne-prone areas (T-zone) and keratosis pilaris with erythema on the arms, the appropriate endocrine work-up should focus on evaluating for PCOS, not Cushing's syndrome. The clinical presentation lacks the specific physical findings that would warrant Cushing's syndrome screening.

Why PCOS Evaluation is Appropriate

The Endocrine Society PCOS guidelines 1 clearly establish that acne is a common cutaneous manifestation of PCOS, present in 14-25% of affected women, particularly in younger patients. The guidelines emphasize that acne, along with other skin findings, should be documented as part of the physical examination in suspected PCOS 1.

PCOS Diagnostic Approach

Make the diagnosis if two of three Rotterdam criteria are met 1:

  • Androgen excess (clinical or biochemical)
  • Ovulatory dysfunction
  • Polycystic ovaries on ultrasound

Required Screening Tests for PCOS Work-up

All women being evaluated for PCOS must be screened with 1:

  • TSH (thyroid disease causes menstrual irregularities)
  • Prolactin (hyperprolactinemia mimics PCOS)
  • 17-hydroxyprogesterone (17-OHP) (excludes non-classic congenital adrenal hyperplasia, found in 1.5-6.8% of hyperandrogenic patients)

Why Cushing's Syndrome Testing is NOT Indicated

The Endocrine Society guidelines on both PCOS and Cushing's syndrome provide clear direction on when to consider Cushing's testing. Cushing's syndrome should only be considered in select women with specific physical findings not associated with PCOS 1.

Red Flags That Would Warrant Cushing's Evaluation

The PCOS guidelines explicitly state that Cushing's testing should be reserved for patients presenting with 1:

  • Proximal muscle weakness (a hallmark of glucocorticoid excess)
  • Wide violaceous (purple) striae (not simple stretch marks)
  • Frontal bossing (acromegaly consideration)
  • Amenorrhea with more severe phenotypes
  • Virilization (not just acne or hirsutism)

Critical Distinction: Redness vs. Plethora

Your patient has "redness...in the T-zone and where acne is present." This is inflammatory erythema from acne, not the facial plethora of Cushing's syndrome. Recent literature confirms that facial plethora in Cushing's syndrome is due to increased perfusion and is a typical sign that resolves immediately after cure 2. The redness associated with acne is localized to lesions, whereas Cushingoid plethora is diffuse facial flushing.

Keratosis Pilaris is Not a Cushing's Feature

The marked erythema on the arms with keratosis pilaris is a common dermatologic finding unrelated to hypercortisolism. Cushing's syndrome presents with specific skin manifestations including violaceous striae, easy bruising, skin fragility, fungal infections, and acanthosis nigricans 2, 3—not keratosis pilaris.

The Evidence on PCOS Misdiagnosis

While one retrospective study found that 50% of reproductive-age women with pathologically proven Cushing's disease had been previously diagnosed with PCOS 4, this does not mean all PCOS patients need Cushing's screening. The key is that those Cushing's patients had hirsutism and menstrual abnormalities as their presenting features—they met criteria that prompted endocrine evaluation, which then revealed hypercortisolism 4.

When to Actually Screen for Cushing's in Young Women

Recent expert consensus 5 clarifies that screening for hypercortisolism in young women with hyperandrogenism and/or menstrual abnormalities should be reserved for those with:

  • Severe or progressive symptoms despite appropriate PCOS treatment
  • Classic Cushingoid physical findings (central obesity with thin extremities, dorsocervical fat pad, wide purple striae, proximal myopathy)
  • Refractory hypertension or difficult-to-control diabetes
  • Unexplained osteoporosis or vertebral fractures

Common Pitfall to Avoid

Do not order Cushing's screening tests (1-mg dexamethasone suppression test, 24-hour urinary free cortisol, late-night salivary cortisol) in patients with simple acne and keratosis pilaris 6, 7, 8. These tests have false-positive rates in conditions like PCOS and obesity—states of "pseudo-Cushing's" or non-neoplastic hypercortisolism 6. Unnecessary testing leads to patient anxiety, additional costly work-up, and potential misdiagnosis.

Recommended Algorithmic Approach

Step 1: Document clinical features

  • Acne distribution and severity
  • Presence/absence of hirsutism (modified Ferriman-Gallwey score)
  • Menstrual history (oligomenorrhea, amenorrhea)
  • Absence of Cushingoid features (proximal weakness, wide purple striae, easy bruising)

Step 2: Order PCOS screening panel

  • TSH
  • Prolactin
  • 17-OHP (morning, follicular phase if cycling)
  • Consider total/free testosterone if hyperandrogenism suspected

Step 3: Assess for Rotterdam criteria

  • If two of three criteria met (after exclusions), diagnose PCOS
  • Document which features led to diagnosis

Step 4: Reserve Cushing's testing ONLY if

  • Patient has proximal muscle weakness, wide violaceous striae, or other specific Cushingoid features
  • PCOS treatment fails and symptoms progress
  • Development of severe, unexplained comorbidities (refractory hypertension, early osteoporosis)

In this patient, proceed with PCOS evaluation and management, not Cushing's syndrome work-up.

References

Research

Skin manifestations of Cushing's syndrome.

Reviews in endocrine & metabolic disorders, 2016

Research

Polycystic ovarian syndrome and Cushing's syndrome: a persistent diagnostic quandary.

European journal of obstetrics, gynecology, and reproductive biology, 2014

Research

Approach to the Patient: Diagnosis of Cushing Syndrome.

The Journal of clinical endocrinology and metabolism, 2022

Related Questions

In a female patient with classic Cushing’s syndrome signs and negative contrast CT scans of the chest, abdomen, and pelvis, could the cause be an upstream source, and should the initial evaluation begin with laboratory testing (cortisol, ACTH, dexamethasone suppression) rather than a physical exam?
What are the clinical manifestations of Cushing disease?
Given normal comprehensive metabolic panel and complete blood count, mildly elevated homocysteine and creatine kinase, positive antinuclear antibody with ribonucleoprotein antibodies, and a spine physician’s suggestion of Cushing’s syndrome, should I be screened for Cushing’s disease and obtain a pituitary magnetic resonance imaging, and can aggressive blood‑pressure control and lifestyle modifications manage my condition?
What laboratory workup is recommended for suspected polycystic ovary syndrome and Cushing's syndrome, and what are the treatment options for Cushing's syndrome?
What detailed questions should be asked for each symptom of Cushing syndrome?
How should I manage a patient with nighttime anxiety who has a PHQ‑9 score of 10 (moderate depression) and a GAD‑7 score of 10 (moderate anxiety)?
How should I manage a patient with acute ear fullness, pressure, muffled hearing, worsening tinnitus, and a history of tympanoplasty?
What is the appropriate spironolactone dose for acne in a 19‑year‑old female?
What is the prevalence of globus sensation in patients with dyspepsia?
What medications are recommended for treating ear congestion (eustachian tube dysfunction)?
How is the Ferriman‑Gallwey (FG) score calculated and interpreted in a woman with acne and facial redness to assess for hirsutism and possible polycystic ovary syndrome (PCOS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.